Question 1

What is HP?

Accepted Answer

HP is the core ecosystem asset defined in the Hippo Protocol whitepaper. The project repository describes Hippo Protocol as a Cosmos SDK application chain for healthcare data; the whitepaper uses HP for decentralized healthcare-data storage, AI-driven services, and governance participation. The whitepaper also describes HP as a new Layer 1 asset transitioning from the former HPO identifier, and links mainnet integration, exchange, and migration to the mainnet launch. The timeline in that document was a plan at the time of publication; that plan alone cannot determine whether migration has now been completed or whether a particular holder's old assets have been automatically converted.

Question 2

What problem does Hippo Protocol primarily address?

Accepted Answer

Hippo Protocol's product direction is healthcare data. The whitepaper envisions data users, AI service providers, and medical institutions using HP to obtain network services and data, placing storage, computing, data processing, and healthcare-related services in the same ecosystem incentive and payment framework. This does not mean holding HP directly grants access to any medical record or healthcare service. Services that can actually be accessed depend on whether the application is integrated, the service provider's rules, and applicable permission and compliance requirements; HP's role in the whitepaper is as a means of payment and incentives within the ecosystem.

Question 3

What is HP used for in the ecosystem?

Accepted Answer

Under the whitepaper design, data users, AI service providers, and medical institutions can use HP to obtain network services and data; HP is also listed as a tool for transaction fees, staking and validator rewards, data-node rewards, and DAO governance. It places users' service use, incentives for network participants, and governance voting in the same token system. The whitepaper's listed AI scenarios include health summaries, consultation support, and data-upload tools that structure files or medical reports; it also lists ecosystem services such as telemedicine, consultations, and clinical-trial matching. These are planned project use cases and do not mean all services are available at all times or in all regions.

Question 4

What can HP holders participate in?

Accepted Answer

The whitepaper lists DAO governance in which HP holders participate in protocol upgrades, policy decisions, and fund allocation as a use case. The proposed community tax fund is likewise governed through on-chain voting, and future uses of funds must be submitted, reviewed, and voted on by HP holders. Therefore, governance rights correspond to a participation mechanism for allocating protocol and ecosystem resources. Whether a proposal passes, voting eligibility, and execution rules still depend on the governance contracts actually deployed and the proposal process at that time; the whitepaper's use description itself is not equivalent to corporate equity, dividends, or redemption arrangements.

Question 5

How is HP's new issuance arranged?

Accepted Answer

The whitepaper proposes that after Hippo Protocol mainnet launches, newly minted HP will be allocated annually under a declining halving-style schedule. Its table lists new issuance for the first six years as 271,183,568, 271,183,568, 135,591,784, 135,591,784, 67,795,892, and 67,795,892 HP, respectively; the corresponding annual inflation rates are 25%, 20%, 8.33%, 7.69%, 3.57%, and 3.45%. These figures are the whitepaper's issuance model, not evidence of actual current on-chain supply or real-time inflation. Determining actual supply at a given point still requires verifiable mainnet and on-chain data.

Question 6

Why is HP issuance used for network rewards?

Accepted Answer

Under the whitepaper's annual new-issuance allocation, 80% is proposed for network rewards; of those network rewards, 90% goes to nodes and 10% to validators. Expressed as proportions of annual new issuance, nodes receive 72% (80% × 90%) and validators receive 8% (80% × 10%). Node incentives are intended to compensate participants who provide storage and computing resources and help maintain the integrity and security of healthcare data; validator incentives are intended to validate transactions and secure the blockchain. The remaining new issuance is proposed in the whitepaper as 10% for ecosystem growth and liquidity incentives, 5% for development grants, and 5% for airdrops and marketing.

Question 7

What is the difference between HP's new issuance and network rewards?

Accepted Answer

HP's issuance model separates “new minting” and “reward allocation” into two levels. First, new HP is produced under the annual issuance schedule; it is then allocated in the whitepaper's proportions to network rewards, ecosystem growth and liquidity incentives, development grants, and airdrops and marketing. Within network rewards, nodes and validators must also be distinguished; not all new issuance should be viewed as staking or validation rewards.

Question 8

What is the difference between the roles of HP nodes and validators?

Accepted Answer

In the whitepaper's architecture, nodes and validators receive HP for different reasons. Nodes provide storage and computing resources to serve healthcare-data integrity and security; validators receive incentives by validating transactions and protecting blockchain security. Both are network participants, but their work and their allocation proportions within network rewards differ.

Question 9

How is HP related to network transaction fees?

Accepted Answer

The whitepaper proposes that HP will be used for transaction fees and uses “Gas-Free Abstraction” to provide a lower-cost, smoother transaction experience within the ecosystem. The token's economic use should be distinguished from the user-interface experience: even if an application abstracts or pays for certain operations for users, the underlying network still needs to define who bears fees and how they are settled.

Question 10

What is the migration relationship between HPO and HP?

Accepted Answer

The whitepaper presents the HPO-to-HP exchange and mainnet migration as plans connected to the mainnet launch, and states that HP will be natively integrated on the mainnet. This wording indicates a migration relationship between old HPO and planned HP, but the page does not provide complete execution information that could confirm whether exchange is currently open, the exchange ratio, deadline, or an individual's asset status.

Question 11

How does HP's community tax fund work?

Accepted Answer

The whitepaper describes the community tax fund as the destination for the remaining newly minted tokens other than validator rewards, and says the fund is governed by the community through on-chain voting. This means fund uses are proposed to be decided through proposals, review, and holder votes, rather than automatically received by a holder at a fixed proportion.

Question 12

How does HP connect service use, network incentives, and governance?

Accepted Answer

HP's whitepaper model connects service demand with token mechanisms: users of data and AI services can use HP to obtain services; network participants such as nodes and validators receive incentives according to their roles; and holders can participate in governing funds and protocol matters. This connection describes the project's designed economic loop and does not mean service usage will necessarily translate into token demand, price, or returns.

Hippo Protocol (HP) Price